Cboe UK EUR

Pharma Mar, S.A. (PHME.XC)

Compare
68.82 0.00 (0.00%)
As of October 16 at 3:10:28 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
167,003.00
158,153.00
196,343.00
229,831.00
269,961.00
Cost of Revenue
9,320.00
9,613.00
13,639.00
16,437.00
13,718.00
Gross Profit
157,683.00
148,540.00
182,704.00
213,394.00
256,243.00
Operating Expense
161,372.00
152,638.00
138,269.00
121,043.00
100,032.00
Operating Income
-3,689.00
-4,098.00
44,435.00
92,351.00
156,211.00
Net Non Operating Interest Income Expense
993.00
1,687.00
-1,501.00
-3,003.00
-2,788.00
Pretax Income
-4,033.00
-3,623.00
43,790.00
95,129.00
145,606.00
Tax Provision
-4,655.00
-4,760.00
-5,566.00
2,270.00
8,344.00
Net Income Common Stockholders
622.00
1,137.00
49,356.00
92,859.00
137,262.00
Diluted NI Available to Com Stockholders
622.00
1,137.00
49,356.00
92,859.00
137,262.00
Basic EPS
0.04
0.06
2.73
5.14
7.50
Diluted EPS
0.04
0.06
2.73
5.13
7.50
Basic Average Shares
17,375.18
17,900.00
18,050.00
18,070.00
18,293.00
Diluted Average Shares
17,375.18
17,916.00
18,063.00
18,085.00
18,325.00
Total Operating Income as Reported
-3,543.00
-3,827.00
44,071.00
92,447.00
155,944.00
Rent Expense Supplemental
--
1,646.00
1,675.00
--
--
Total Expenses
170,692.00
162,251.00
151,908.00
137,480.00
113,750.00
Net Income from Continuing & Discontinued Operation
622.00
1,137.00
49,356.00
92,859.00
137,262.00
Normalized Income
361.75
783.00
51,045.00
92,754.55
137,513.70
Interest Income
3,409.00
4,103.00
875.00
370.00
336.00
Interest Expense
4,542.00
2,416.00
2,376.00
3,373.00
3,124.00
Net Interest Income
993.00
1,687.00
-1,501.00
-3,003.00
-2,788.00
EBIT
-798.00
-1,207.00
46,166.00
98,502.00
148,730.00
EBITDA
5,343.00
4,549.00
52,066.00
104,085.00
155,941.00
Reconciled Cost of Revenue
9,320.00
9,613.00
13,639.00
16,437.00
13,718.00
Reconciled Depreciation
6,141.00
5,756.00
5,900.00
5,583.00
7,211.00
Net Income from Continuing Operation Net Minority Interest
622.00
1,137.00
49,356.00
92,859.00
137,262.00
Total Unusual Items Excluding Goodwill
347.00
472.00
-2,252.00
107.00
-267.00
Total Unusual Items
347.00
472.00
-2,252.00
107.00
-267.00
Normalized EBITDA
4,996.00
4,077.00
54,318.00
103,978.00
156,208.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
86.75
118.00
-563.00
2.55
-15.30
12/31/2020 - 11/3/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade